A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
Its recent patent adds to several for cryogenic storage that works in tandem with server farms.
Using fake data is “not a panacea” to the security woes these models face.
Despite the buzz, the promises of this tech may be “underhyped,” one expert said.